PMO-145 Ethnicity Has No Impact on SVR Rates in Patients With HCV Genotype 3 Treated With Pegylated Interferon and Ribavirin: Abstract PMO-145 Figure 1

Gut - United Kingdom
doi 10.1136/gutjnl-2012-302514b.145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy